stockportfolio.pro
Stocks / CNTA vs PTCT
CNTA vs PTCT
Centessa Pharmaceuticals plc and PTC Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Centessa Pharmaceuticals plc (CNTA) | PTC Therapeutics, Inc. (PTCT) | |
|---|---|---|
| Market cap | $6.1B | $6.1B |
| Revenue (latest FY) | $15.00M | $1.73B |
| Net income (latest FY) | $-197.53M | $682.64M |
| Revenue growth (5y CAGR) | — | 35.4% |
| Net margin | -1316.9% | 39.4% |
| Return on equity | -37.5% | -332.5% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 1 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CNTA — free Open PTCT — freeFrequently asked questions
Which is bigger, CNTA or PTCT?
Centessa Pharmaceuticals plc is larger by market capitalization — $6.1B versus $6.1B.
Which grows faster, CNTA or PTCT?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.